• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1
1
1
1

COUNTRY

1

CATEGORIES

  • 16
  • 5
  • 4
  • 1
  • 1
  • 1
  • 1

PRICE

1
7
11
29

PUBLISHED

0
3
13
29

PRODUCT TYPE

18
11

Search "ImmunoCellular Therapeutics, Ltd-Detailed Product Pipeline" returned 29 results.

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015 Summary This, ‘ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015’, provides an overview of the ImmunoCellular Therapeutics,...

May 2015
FROM

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2013

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2013 Summary “ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2013” provides data on the ImmunoCellular Therapeutics, Ltd.’s...

December 2013
FROM

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2014

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2014’, provides an overview of the...

May 2014
FROM

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update

Summary ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company...

May 2013
FROM

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2012

ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2012” provides...

May 2012
FROM

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2015
FROM

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - Q4 2010

ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - Q4 2010”...

December 2010
FROM

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis Summary ImmunoCellular Therapeutics, Ltd. (ImmunoCellular) is a clinical-stage biotechnology company. It undertakes the development...

May 2012
FROM

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015 Summary This, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Recurrent Glioblastoma...

March 2015
FROM

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014 Summary This, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014’, provides an overview of the Recurrent Glioblastoma...

November 2014
FROM

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014 Summary This, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2014’, provides an overview of the Multiple Myeloma (Kahler's...

September 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

April 2014
FROM

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

May 2014
FROM

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2014’, provides an overview of the...

June 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2014

Small-Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

July 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Colon Cancer - Pipeline Review, H2 2014

Colon Cancer - Pipeline Review, H2 2014 Summary This, ‘Colon Cancer - Pipeline Review, H2 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Epithelial Ovarian Cancer - Pipeline Review, H1 2015

Epithelial Ovarian Cancer - Pipeline Review, H1 2015 Summary This, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline. This...

May 2015
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG